Equities researchers at StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report released on Sunday. The brokerage set a “hold” rating on the stock. Galectin Therapeutics Stock Performance GALT stock opened at $1.44 on Friday. The firm has a market cap of $85.62 million, a P/E ratio of -2.15 […]
StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Friday, March 3rd. Galectin […]
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, […]
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research report sent to investors on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, […]
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note issued on Thursday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $11.00 price target on shares of Galectin Therapeutics in a research note on Friday, March 3rd. Galectin […]